In lab and animal studies, yes. Curcumin lowered MMP13 in rat cartilage cells exposed to IL-1 beta, and a curcumin metabolite bound and blocked MMP13 directly and protected cartilage in rats. No study here measured MMP13 in people taking curcumin, and curcumin taken on its own is poorly absorbed.
Wang and colleagues gave rat cartilage cells IL-1 beta, which raised MMP13 and lowered type II collagen, with or without curcumin (Wang 2017). Curcumin blocked IL-1 beta's activation of NF-kB, a switch that controls both genes. MMP13 fell and type II collagen rose, and the cells multiplied more (Wang 2017). The abstract doesn't give the curcumin concentration.
A 2025 study took a different route. Curcumin monoglucuronide, a metabolite of curcumin, had looked in computer modelling as if it would bind to cartilage-cutting MMPs. Roy and colleagues confirmed that it binds and blocks MMP13 and MMP-8 (Roy 2025).
They then tested it at two levels. In cartilage samples in the lab it protected against MMP-driven breakdown. In rats whose knee ligament had been cut, it was more effective at preventing cartilage degeneration than BI-4394, a drug designed to block MMP13 (Roy 2025). It didn't affect the cells' NF-kB-driven inflammatory genes, which suggests it works on the enzyme rather than the signal.
Jhun and colleagues tested curcumin with omega-3. In human cartilage cells from damaged joints, stimulated with IL-1 beta, the combination lowered MMP1, MMP3 and MMP13 gene activity (Jhun 2025). In rats with chemically induced knee damage, oral curcumin with omega-3 lessened pain behaviour and conserved cartilage (Jhun 2025). The abstract doesn't separate curcumin's effect on MMP13 from omega-3's in the cell work.
Curcumin is hard to get into the blood. In a 1998 study, human volunteers given 2 g of curcumin alone had serum levels that were undetectable or very low (Shoba 1998). Taking 20 mg of piperine, from black pepper, with it raised the extent of absorption by 2000%. In rats the increase was 154% (Shoba 1998). Piperine is a known inhibitor of glucuronidation in the liver and intestine, part of the rapid metabolism that keeps curcumin out of the blood (Shoba 1998).
That sits awkwardly with the 2025 finding. Curcumin monoglucuronide is a product of glucuronidation, the very step piperine slows (Shoba 1998; Roy 2025). No study here has tested how the two interact.
Among the ingredients on this site, curcumin has some of the most MMP13 research. It is still lab-stage evidence.
No. Curcumin is a compound from the turmeric root, Curcuma longa. Turmeric is the whole spice.
Piperine from black pepper slows the body's breakdown of curcumin. In human volunteers, adding 20 mg of piperine to 2 g of curcumin raised absorption by 2000%.
Not in any study on this site. The MMP13 findings come from cartilage cells, cartilage samples and rats.
In animal and lab studies, yes. AKBA, the lead boswellic acid, suppressed MMP13 in rats with chemically induced knee damage, and a frankincense extract lowered MMP13...
Yes, in lab studies. The inflammatory messenger IL-1 raised MMP13 in human cartilage and cartilage cells in several studies, and TNF-alpha did too. To switch the MMP13...
Because it acts at the step reviews call irreversible. MMP13 is the main enzyme cutting type II collagen in damaged cartilage, and that collagen renews very slowly. Mice...
The lab evidence is thin and mixed. Glucosamine lowered MMP13 in one study of human cartilage cells and stem cells, but in another it didn't change cytokine-driven...